ArticleNpj viruses2026
Isolation of novel phages from a resistant Dorea longicatena strain reveals genes associated with phage resistance.
Article in Npj viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The gut bacterium Dorea longicatena has been reported to be closely associated with metabolic disorders and has emerged as a promising target for microbiome interventions aiming at improving metabolic diseases. While phages serve as effective tools for precise modulation of gut bacteria, phage resources against this and other obligate anaerobic gut bacteria remain extremely limited, hindering both therapeutic development and studies of phage-host interactions. To address this gap and the challenge of rapid resistance emergence, we performed sequential screening by first generating phage-resistant D. longicatena mutants using a previously reported set of D. longicatena phages and then using these resistant mutants as hosts to isolate additional phages from environmental samples. This approach yielded two novel lytic phages, CPB1657 and CPB1660, which remained active against 27 of the 30 tested D. longicatena strains, including the wild-type strain and resistant derivatives. Genomic characterization confirmed their lytic properties and absence of virulence or lysogeny genes. In addition, resistance to the initial phage was strongly associated with mutations in the major tail protein-like gene MAG_TPA_asm. Several mutants resistant to all tested phages shared an identical set of seven missense mutations in this gene. Together, these findings expand the currently limited phage resources available for D. longicatena and provide new insight into phage-host interactions in anaerobic gut bacteria.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.